Comments to FDA: Urinary Analgesic Drugs

CHPA submits these comments on behalf of member companies who market OTC drugs for urinary pain relief. Our comments are in response to FDA’s notice requesting information about marketed urinary analgesic/antiseptic drug products that have not yet undergone FDA evaluation.